US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 40.960
  • -0.160-0.39%
Close Jul 2 16:00 ET
  • 39.000
  • -1.960-4.79%
Post 17:52 ET
3.71BMarket Cap-5152P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Ultragenyx Pharmaceutical Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

108.83M

+8.30%
EPS(YoY)

-2.03

+12.88%

Strong Buy

Jun 30, 2024

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 131.693M--
--2024/Q2-- / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
Feb 15, 20242023/Q4127.392M / 120.989M--
Nov 2, 20232023/Q398.052M / 102.875M--
Aug 3, 20232023/Q2108.309M / 104.987M--
May 4, 20232023/Q1100.496M / 103.902M--
Feb 16, 20232022/Q4103.348M / 105.114M--
Nov 2, 20222022/Q390.703M / 95.704M--
Jul 28, 20222022/Q289.343M / 87.332M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 131.693M--
--2024/Q2-- / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
Feb 15, 20242023/Q4127.392M / 120.989M--
Nov 2, 20232023/Q398.052M / 102.875M--
Aug 3, 20232023/Q2108.309M / 104.987M--
May 4, 20232023/Q1100.496M / 103.902M--
Feb 16, 20232022/Q4103.348M / 105.114M--
Nov 2, 20222022/Q390.703M / 95.704M--
Jul 28, 20222022/Q289.343M / 87.332M--

Unlock Free Earnings Estimates

Ultragenyx Pharmaceutical Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 30, 2024

Strong Buy

  • Buy

    94.44%
  • Hold

    5.56%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg